J&J’s booster shot provides strong protection against severe disease from Omicron, a study says.

Health
By BY CARL ZIMMER from NYT Health https://ift.tt/3sIzTmd
via IFTTT Coronavirus Omicron Variant, Clinical Trials, Vaccination and Immunization, Coronavirus (2019-nCoV), Research, Drugs (Pharmaceuticals) Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda